Nautilus Biotechnology, Inc. (NAUT) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Nautilus Biotechnology, Inc. (NAUT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $374.9M, listed on NASDAQ, employing roughly 134 people, carrying a beta of 0.75 to the broader market. Nautilus Biotechnology, Inc. Led by Sujal Patel, public since 2020-08-07.
Snapshot as of May 15, 2026.
- Spot Price
- $2.51
- Total OI
- 2.6K